Novavax
Late-stage biotechnology company focused on the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. Learn more
Launch date
Employees
Market cap
$1.9b
Enterprise valuation
$1.1b (Public information from Sep 2024)
Share price
$12.52 NVAX
Gaithersburg Maryland (HQ)
Authorizing premium user...